Ojikutu Bisola, Jack Chris, Ramjee Gita
Division of AIDS, Harvard Medical School, Boston, Massachusetts 02215, USA.
J Infect Dis. 2007 Dec 1;196 Suppl 3:S523-7. doi: 10.1086/521119.
From 2003 to 2006, the number of human immunodeficiency virus-infected people in sub-Saharan Africa able to access antiretroviral therapy (ART) has increased from 100,000 to >1 million. The World Health Organization estimates that >3.5 million patients are still in need. The challenges to more expeditious provision of ART in Africa are many. This article is an analysis of the barriers to ART scale-up that are unique to South Africa. With 5.3 million people infected and 1 million needing ART, this country carries nearly one-quarter of the treatment burden of the continent. Although South Africa is undeniably a middle-income nation, inequities born of apartheid, lack of political commitment, poverty, and cultural barriers have significantly slowed efforts to provide universal access to ART to South African citizens.
2003年至2006年期间，撒哈拉以南非洲地区能够获得抗逆转录病毒疗法（ART）的人类免疫缺陷病毒感染者人数已从10万增至100多万。世界卫生组织估计，仍有超过350万患者需要治疗。在非洲更快地提供抗逆转录病毒疗法面临诸多挑战。本文分析了南非特有的扩大抗逆转录病毒疗法规模的障碍。该国530万人感染，100万人需要抗逆转录病毒疗法，承担着非洲大陆近四分之一的治疗负担。尽管南非无疑是一个中等收入国家，但种族隔离造成的不平等、缺乏政治承诺、贫困和文化障碍，已严重减缓了为南非公民普及抗逆转录病毒疗法的努力。
